Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Amortization - Goodwill Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Outstanding Shares Outstanding Shares Repurchased

Mesa Laboratories (MLAB) Shares Issued (2016 - 2023)

Mesa Laboratories (MLAB) has disclosed Shares Issued for 14 consecutive years, with $2000.0 as the latest value for Q4 2023.

Quarterly Shares Issued fell 99.35% to $2000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $358000.0 through Mar 2024, down 94.88% year-over-year, with the annual reading at $2.6 million for FY2025, 638.55% up from the prior year.
Shares Issued hit $2000.0 in Q4 2023 for Mesa Laboratories, down from $304000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $164.4 million in Q3 2019 to a low of -$143.2 million in Q3 2020.
Historically, Shares Issued has averaged -$2.0 million across 5 years, with a median of $1.4 million in 2022.
Biggest YoY gain for Shares Issued was 123479.7% in 2019; the steepest drop was 20021.12% in 2019.
Year by year, Shares Issued stood at -$82.1 million in 2019, then surged by 101.21% to $991000.0 in 2020, then skyrocketed by 211.81% to $3.1 million in 2021, then tumbled by 90.06% to $307000.0 in 2022, then crashed by 99.35% to $2000.0 in 2023.
Business Quant data shows Shares Issued for MLAB at $2000.0 in Q4 2023, $304000.0 in Q3 2023, and $52000.0 in Q2 2023.